Skip to main content
. 2021 Jun 5;3:100083. doi: 10.1016/j.ijpx.2021.100083

Table 1.

Pharmacokinetic study design.

Formulation Average body weight (g) Animals (n) Dose (mg/kg bw) Dose volume (mL/kg) Dose volume (mL)
IV 340 ± 2 3 2.00 1.20 0.41
Nanocrystals 344 ± 7 5 2.40 5.00 1.72
Amorphous form 343 ± 7 5 2.40 5.00 1.72
DES formulation 350 ± 10 5 2.40 0.43 0.14
DES formulation with 10 wt% HPMC 357 ± 11 5 2.40 0.47 0.16